A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain

Clinical trial NCT00364546 · COMPLETED

Trial details

NCT number: NCT00364546
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoarthritis Pain Intensity Assessment Arthralgia Sciatica Low Back Pain

Start date: 2006-07-01
Primary completion: 2007-06-01
Enrollment: 877

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.